File Download

There are no files associated with this item.

Supplementary

Conference Paper: Development of a Favipiravir-Theophylline Inhalable Cocrystal Formulation for Potential Respiratory Viral Infections

TitleDevelopment of a Favipiravir-Theophylline Inhalable Cocrystal Formulation for Potential Respiratory Viral Infections
Authors
WONG, SNChen, RLakerveld, RChow, SF
Issue Date2021
Citation
Controlled Release Society 2021 Virtual Annual Meeting, 25-29 July 2021 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/301714

 

DC FieldValueLanguage
dc.contributor.authorWONG, SN-
dc.contributor.authorChen, R-
dc.contributor.authorLakerveld, R-
dc.contributor.authorChow, SF-
dc.date.accessioned2021-08-09T03:43:09Z-
dc.date.available2021-08-09T03:43:09Z-
dc.date.issued2021-
dc.identifier.citationControlled Release Society 2021 Virtual Annual Meeting, 25-29 July 2021-
dc.identifier.urihttp://hdl.handle.net/10722/301714-
dc.languageeng-
dc.relation.ispartofControlled Release Society 2021 Virtual Annual Meeting-
dc.titleDevelopment of a Favipiravir-Theophylline Inhalable Cocrystal Formulation for Potential Respiratory Viral Infections-
dc.typeConference_Paper-
dc.identifier.emailChow, SF: asfchow@hku.hk-
dc.identifier.authorityChow, SF=rp02296-
dc.identifier.hkuros323907-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats